Fate Therapeutics, Inc.FATENASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-112.04M
Near historical average
Percentile
P29
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-111.60M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-112.04M | +9.4% |
| 2024 | $-123.60M | +10.7% |
| 2023 | $-138.42M | +51.2% |
| 2022 | $-283.77M | -32.9% |
| 2021 | $-213.57M | -383.6% |
| 2020 | $-44.16M | +51.2% |
| 2019 | $-90.57M | -121.2% |
| 2018 | $-40.95M | -6.0% |
| 2017 | $-38.63M | -27.6% |
| 2016 | $-30.28M | - |